Zhang J C, Sakthivel R, Kniss D, Graham C H, Strickland D K, McCrae K R
Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
J Biol Chem. 1998 Nov 27;273(48):32273-80. doi: 10.1074/jbc.273.48.32273.
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor (LRP/alpha2MR) mediates the internalization of numerous ligands, including prourokinase (pro-UK) and complexes between two-chain urokinase (tc-u-PA) and plasminogen activator inhibitor type-1 (PAI-1). It has been suggested that through its ability to internalize these ligands, LRP/alpha2MR may regulate the expression of plasminogen activator activity on cell surfaces; this hypothesis, however, has not been experimentally confirmed. To address this issue, we assessed the ability of LRP/alpha2MR to regulate plasminogen activator activity on human trophoblast cells, which express both LRP/alpha2MR and the urokinase receptor (uPAR). Trophoblasts internalized and degraded exogenous 125I-pro-UK (primarily following its conversion to tc-u-PA and incorporation into tc-u-PA.PAI complexes) in an LRP/alpha2MR-dependent manner, which was inhibited by the LRP/alpha2MR receptor-associated protein. Receptor-associated protein also caused a approximately 50% reduction in cell surface plasminogen activator activity and delayed the regeneration of unoccupied uPAR by cells on which uPAR were initially saturated with pro-UK. Identical effects were caused by anti-LRP/alpha2MR antibodies. These results demonstrate that LRP/alpha2MR promotes the expression of cell surface plasminogen activator activity on trophoblasts by facilitating the clearance of tc-u-PA.PAI complexes and regeneration of unoccupied cell surface uPAR.
低密度脂蛋白受体相关蛋白/α2-巨球蛋白受体(LRP/α2MR)介导多种配体的内化,包括单链尿激酶型纤溶酶原激活物(pro-UK)以及双链尿激酶(tc-u-PA)与纤溶酶原激活物抑制剂1型(PAI-1)之间的复合物。有人提出,通过内化这些配体的能力,LRP/α2MR可能调节细胞表面纤溶酶原激活物活性的表达;然而,这一假设尚未得到实验证实。为了解决这个问题,我们评估了LRP/α2MR调节人滋养层细胞表面纤溶酶原激活物活性的能力,这些细胞同时表达LRP/α2MR和尿激酶受体(uPAR)。滋养层细胞以LRP/α2MR依赖的方式内化并降解外源性125I-pro-UK(主要是在其转化为tc-u-PA并掺入tc-u-PA.PAI复合物之后),这一过程受到LRP/α2MR受体相关蛋白的抑制。受体相关蛋白还使细胞表面纤溶酶原激活物活性降低了约50%,并延迟了uPAR最初被pro-UK饱和的细胞上未占据的uPAR的再生。抗LRP/α2MR抗体也产生了相同的效果。这些结果表明,LRP/α2MR通过促进tc-u-PA.PAI复合物的清除和未占据的细胞表面uPAR的再生,促进滋养层细胞表面纤溶酶原激活物活性的表达。